Definitive Contract N6600113C4025
Award Date
6/25/13
Potential Completion Date
5/31/23
Potential Value
$25M
Funding Federal Agency
Defense Advanced Research Projects Agency
Contracting Federal Agency
Naval Information Warfare Systems Command
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AD21 - R&D- Defense Other: Services (Basic Research)
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
12
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for BIOMEDICAL (APPLIED/EXPLORATORY) research and development work, with a ceiling value of $621,724.00. The contract was awarded by the U.S. government to the Massachusetts Institute of Technology (MIT) on April 1, 2009, with a planned completion date of December 31, 2009. The contract is part of the GENOMIC SEQUENCING CENTERS FOR INFECTIOUS DISEASES major program and is a definitive contract with a cost-no-fee pricing type. The work is being performed in...
Massachusetts Institute of Technology (MIT) has been awarded a definitive cost-no-fee contract valued at $5,914,574 by the Defense Advanced Research Projects Agency (DARPA) to conduct research in genetic circuit design for extreme environments enabled by models extracted from petabyte-scale perturbation data. Work will be performed in Cambridge, Massachusetts through March 31, 2022. No set-aside designation was used for this award issued under the agency's open market authority. MIT will serve...
This is a federal contract award from the Defense Advanced Research Projects Agency (DARPA) to the Massachusetts Institute of Technology (MIT) for the development of a "Pharmacy on Demand - Compact, On-Demand Continuous Flow Manufacturing of Pharmaceuticals." The contract has a ceiling value of $996,373.00 and a period of performance ending on July 22, 2017. It is a definitive contract with a cost-no-fee pricing type, with no set-aside designation. As a subcontract under this award,...
This is a federal contract award from the Defense Advanced Research Projects Agency (DARPA) to the Massachusetts Institute of Technology (MIT) for the BRICS PROGRAM - ROBUST: ROBUST OPERATION OF BACTERIAL UNIVERSES WITH SYNTHETIC-BIOLOGY TECHNOLOGIES. The $3,998,381.00 definitive contract has a period of performance ending on June 28, 2018. The contract was not set aside for any specific business category. MIT is the prime contractor, and Boston University and Yale University are the major...
This federal contract award, valued at $11,348,590.00, was issued by the National Institutes of Health (NIH) to the Massachusetts Institute of Technology (MIT) under an Other Transaction Agreement. The contract, titled "ARPA-H ADAPT AURORA: AI-DRIVEN UNDERSTANDING OF RESPONSE OPTIMIZATION AND RESISTANCE ASSESSMENT," is focused on advanced research and development in artificial intelligence and related technologies. The award does not have a set-aside designation, indicating MIT's broad...
This is a definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to the Massachusetts Institute of Technology (MIT) on September 27, 2017 for the project "BAYESDB FOR DATA CENTRIC SCIENTIFIC DISCOVERY". The total potential value of the contract is $3,869,595.00. The contract is for cost-no-fee work and does not have a set-aside designation. MIT is a private research university located in Cambridge, Massachusetts that has extensive experience conducting...
The federal contract award to the Massachusetts Institute of Technology (MIT) has an award value of $25,500.00 and is a purchase order with an ultimate completion date of May 1, 2008. The contract was awarded on March 13, 2007 by a U.S. government agency and does not have a set-aside designation. MIT frequently partners with federal agencies like the Department of Defense, Department of Energy, and NASA to conduct scientific research and development across various technical domains. This...
This is a federal contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to the Massachusetts Institute of Technology (MIT) for an Indefinite Delivery/Indefinite Quantity (IDIQ) Other Transaction Authority (OTA) contract. The $11,982,216.00 contract supports basic research under the UARC (University-Affiliated Research Center) program, with a period of performance through June 30, 2023. The contract has no set-aside designation. MIT, a world-class private...
This is a $995,000.00 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to the Massachusetts Institute of Technology (MIT) on December 7, 2015. The contract is for a "Pharmacy on Demand Demonstration" with a final completion date of July 22, 2017. The contract does not have a set-aside designation. As a subcontractor under the prime contract, Valco Instruments Co Inc. was awarded $Y4K5Y5DYNMJ8 on March 31, 2016 to provide a "Synthesis System...
This is a delivery order contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the Massachusetts Institute of Technology (MIT) on February 8, 2013. The contract, titled "ISN UARC (BASIC RESEARCH)", has a potential value of $5,115,233.21 and is set to be completed by December 31, 2022. The contract is a cost-sharing arrangement and is not set aside for any specific business designation. MIT is a private research university that...